HER2+

491 views 53 hours watched
03:06

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Insights: PATINA Trial - Palbociclib Combined With Endocrine and HER2-Targeted Therapy in ER+/HER2+ mBC

FEATURING Komal Jhaveri
  • 3 views
  • January 8, 2025
01:56

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Insights: PATINA Trial - CDK4/6 Inhibitors in Maintenance Therapy for HER2+ mBC

FEATURING Erika Hamilton
  • 9 views
  • January 7, 2025
04:38

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Insights: neoHIP Study of Neoadjuvant HER2-Targeted Therapy +/- IO With Pembrolizumab

FEATURING Heather McArthur
  • 33 views
  • January 2, 2025
  • 2
14:36

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Insights: PATINA - Monday Morning Practice

FEATURING Sara Tolaney, Hope Rugo
  • 339 views
  • December 22, 2024
  • 8
05:50

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Insights: Effectiveness of Post-T-DXd Treatments in HER2+ mBC - EN-SEMBLE Study

FEATURING Kazuki Nozawa
  • 97 views
  • December 20, 2024
  • 4
02:18

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Insights: EmpowHER 303 - Zanidatamab vs. Trastuzumab + Chemo in HER2+ mBC Post-T-DXd

FEATURING Sara Tolaney
  • 9 views
  • December 17, 2024